Life sciences & healthcare
Click here to find out more
Targeted treatments – Part 3: the power of orphan drug protection
15 October 2020
Quick read
Life sciences & healthcare
Click here to find out more
How to prepare for the MHRA's new medical devices enforcement rules
8 October 2020
Briefing
by multiple authors
Life sciences & healthcare
Click here to find out more
German Federal Court of Justice invalidates Truvada SPC
7 October 2020
Life sciences & healthcare
Click here to find out more
Targeted treatments – Part 2: the SPCs for new indications debacle
2 October 2020
Briefing
Life sciences & healthcare
Click here to find out more
Targeted treatments – Part 1: Targeted treatments: patents for particular populations
23 September 2020
Quick read
Disputes & investigations
Click here to find out more
Goodbye CE, hello UKCA
18 September 2020
QUICK READ
by multiple authors
Life sciences & healthcare
Click here to find out more
CJEU ruling to liberalise parallel import in Poland
25 August 2020
IN-DEPTH ANALYSIS
Life sciences & healthcare
Click here to find out more
Biologics and biosimilars litigation update
7 August 2020
QUICK READ
Brexit
Click here to find out more
Brexit readiness for overseas medical devices manufacturers: trade marks
6 August 2020
QUICK READ
by multiple authors
Life sciences & healthcare
Click here to find out more
Return to work: key issues for life sciences
4 August 2020
QUICK READ
by Helen Farr and Adrian Toutoungi
Synapse
Click here to find out more
Private equity investment in life sciences sector
30 July 2020
IN-DEPTH ANALYSIS
by multiple authors
Life sciences & healthcare
Click here to find out more
Licensing out: Try not to get benched
27 July 2020
IN-DEPTH ANALYSIS
by Colin McCall and Justyna Ostrowska